Literature DB >> 21549137

Neurobiology of aversive states.

Erin N Umberg1, Emmanuel N Pothos.   

Abstract

Hoebel and colleagues are often known as students of reward and how it is coded in the CNS. This article, however, attempts to focus on the significant advances by Hoebel and others in dissecting out behavioral components of distinct aversive states and in understanding the neurobiology of aversion and the link between aversive states and addictive behaviors. Reward and aversion are not necessarily dichotomous and may reflect an affective continuum contingent upon environmental conditions. Descriptive and mechanistic studies pioneered by Bart Hoebel have demonstrated that the shift in the reward-aversion spectrum may be, in part, a result of changes in central dopamine/acetylcholine ratio, particularly in the nucleus accumbens. The path to aversion appears to include a specific neurochemical signature: reduced dopamine release and increased acetylcholine release in "reward centers" of the brain. Opioid receptors may have a neuromodulatory role on both of these neurotransmitters.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549137      PMCID: PMC3116693          DOI: 10.1016/j.physbeh.2011.04.045

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  192 in total

1.  Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission.

Authors:  Keiichi Niikura; Minoru Narita; Eduardo R Butelman; Mary Jeanne Kreek; Tsutomu Suzuki
Journal:  Trends Pharmacol Sci       Date:  2010-05-12       Impact factor: 14.819

2.  Oscillations in the basolateral amygdala: aversive stimulation is state dependent and resets the oscillatory phase.

Authors:  James W Crane; Francois Windels; Pankaj Sah
Journal:  J Neurophysiol       Date:  2009-07-01       Impact factor: 2.714

3.  Influence of intrastriatal infusion of dynorphin fragments on overflow of acetylcholine and dopamine in the rat brain.

Authors:  Amar K Pani
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

Review 4.  Dopamine receptor agonists and depression in Parkinson's disease.

Authors:  Marina Picillo; Mariangela Rocco; Paolo Barone
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

5.  State sadness reduces neural sensitivity to nonrewards versus rewards.

Authors:  Dan Foti; Greg Hajcak
Journal:  Neuroreport       Date:  2010-01-27       Impact factor: 1.837

6.  Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.

Authors:  Luis A Natividad; Hugo A Tejeda; Oscar V Torres; Laura E O'Dell
Journal:  Synapse       Date:  2010-02       Impact factor: 2.562

7.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

Review 8.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

9.  Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder.

Authors:  Gregor Hasler; David A Luckenbaugh; Joseph Snow; Noah Meyers; Tracy Waldeck; Marilla Geraci; Jonathan Roiser; Brian Knutson; Dennis S Charney; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2009-04-25       Impact factor: 13.382

Review 10.  kappa-Opioid receptor signaling and brain reward function.

Authors:  Adrie W Bruijnzeel
Journal:  Brain Res Rev       Date:  2009-10-02
View more
  7 in total

Review 1.  The ascending mesolimbic cholinergic system--a specific division of the reticular activating system involved in the initiation of negative emotional states.

Authors:  Stefan M Brudzynski
Journal:  J Mol Neurosci       Date:  2013-11-24       Impact factor: 3.444

2.  Morphine dependence and withdrawal induced changes in cholinergic signaling.

Authors:  Nichole M Neugebauer; Emily B Einstein; Maria B Lopez; Tristan D McClure-Begley; Yann S Mineur; Marina R Picciotto
Journal:  Pharmacol Biochem Behav       Date:  2013-05-04       Impact factor: 3.533

3.  A history of bingeing on fat enhances cocaine seeking and taking.

Authors:  Matthew D Puhl; Angie M Cason; Francis H E Wojnicki; Rebecca L Corwin; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2011-10-10       Impact factor: 1.912

4.  Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.

Authors:  Paul R Burghardt; Amy E Rothberg; Kate E Dykhuis; Charles F Burant; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2015-06-24       Impact factor: 5.958

Review 5.  Aversive motivation and cognitive control.

Authors:  Debbie M Yee; Xiamin Leng; Amitai Shenhav; Todd S Braver
Journal:  Neurosci Biobehav Rev       Date:  2021-12-12       Impact factor: 8.989

6.  Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine.

Authors:  Dusica Bajic; Mariano Soiza-Reilly; Allegra L Spalding; Charles B Berde; Kathryn G Commons
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  A Potential Animal Model of Maladaptive Palatable Food Consumption Followed by Delayed Discomfort.

Authors:  Lital Moshe; Liza Bekker; Aron Weller
Journal:  Front Neurosci       Date:  2017-07-05       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.